CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy) One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure Radial Versus Femoral Access for Rotational Atherectomy: A UK Observational Study of 8622 Patients

Original Research2006 Mar 23;354(12):1264-72.

JOURNAL:N Engl J Med. Article Link

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

Cohen JC, Boerwinkle E, Mosley TH Jr et al. Keywords: PCSK9; Low LDL; CHD

FULL TEXT PDF